Brainstorm Cell Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $29.3M
Liabilities Breakdown FY2021
Total Liabilities: $9.9M
Asset Breakdown
Total Assets: $29.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.9M | 64.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.2M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.2M | 31.5% |
Liabilities Breakdown
Total Liabilities: $9.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 37.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.2M | 62.8% |